Is Tilray Brands (TLRY) Now An Opportunity After Prolonged Share Price Weakness

Simply Wall St

Tue, February 17, 2026 at 5:08 PM GMT+9 6 min read

In this article:

TLRY

+0.27%

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

If you are wondering whether Tilray Brands at around US$7.51 is a bargain or a value trap, you are not alone; many investors are asking the same question.

The stock has been volatile recently, with returns of a 4.1% decline over the past week, a 20.6% decline over the past month, a 22.7% decline year to date, and a 16.1% decline over the past year, while the 3-year return sits at a 73% decline.

Recent coverage around Tilray Brands has focused on its position in the cannabis and consumer packaged goods space, including how it is trying to strengthen its brands and product footprint. This context helps frame why the share price has been under pressure and why some investors are reassessing the risk and potential reward in the stock.

On our checks, Tilray Brands scores a 5 out of 6 valuation score. We will break this down using several common valuation approaches before turning to a more complete way to think about what that score really means for long-term investors.

Find out why Tilray Brands’s -16.1% return over the last year is lagging behind its peers.

Approach 1: Tilray Brands Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes estimates of a company’s future cash flows and discounts them back to today using a required rate of return, giving you an estimate of what the whole business might be worth now.

For Tilray Brands, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is a loss of about $61.9 million, so the starting point is negative. Analysts provide free cash flow estimates out to 2029, and Simply Wall St extrapolates further so that by 2035 the projected free cash flow is $57.4 million. All of these cash flows are in $ and are discounted back to today, then combined with a terminal value.

On this basis, the DCF model estimates an intrinsic value of about $9.65 per share, compared with the current price of around $7.51. That implies the shares trade at roughly a 22.2% discount to this DCF estimate, which indicates the stock is potentially undervalued on these cash flow assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Tilray Brands is undervalued by 22.2%. Track this in your watchlist or portfolio, or discover 55 more high quality undervalued stocks.

TLRY Discounted Cash Flow as at Feb 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Tilray Brands.

Story Continues  

Approach 2: Tilray Brands Price vs Sales

For companies where earnings are weak or inconsistent, the P/S ratio is often more useful than P/E, because it compares the share price to revenue rather than profits that may still be in the red.

What counts as a “normal” or “fair” P/S ratio usually reflects how quickly revenue is expected to grow and how risky the business is. Higher expected growth and lower risk can justify a higher multiple, while slower growth or higher risk usually support a lower one.

Tilray Brands currently trades on a P/S ratio of about 1.04x. That is well below the Pharmaceuticals industry average of 4.30x and also below the peer group average of 10.18x. On the surface, that might suggest the shares are priced more conservatively than many peers.

Simply Wall St’s Fair Ratio for Tilray Brands is 1.81x. This is a proprietary estimate of the P/S multiple that would be reasonable given the company’s earnings profile, revenue growth outlook, profit margins, industry, market cap and specific risks. Because it is tailored to the company, it can be more informative than a simple comparison with broad industry or peer averages.

With the current P/S ratio of 1.04x sitting below the Fair Ratio of 1.81x, Tilray Brands screens as undervalued on this metric.

Result: UNDERVALUED

NasdaqGS:TLRY P/S Ratio as at Feb 2026

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 23 top founder-led companies.

Upgrade Your Decision Making: Choose your Tilray Brands Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. These are simple stories you create about Tilray Brands that connect your view of its future revenue, earnings and margins to a financial forecast, a fair value, and ultimately a comparison between that fair value and today’s price. This can be done on Simply Wall St’s Community page, where millions of investors share views. Each Narrative updates automatically when new news or earnings arrive and can potentially range from a cautious story that points to a fair value of about US$0.60 to a more optimistic story closer to US$2.00 per share.

For Tilray Brands, we will make it really easy for you with previews of two leading Tilray Brands narratives:

Each one connects a clear set of assumptions on growth, margins and valuation to a specific fair value, so you can see which story sits closer to your own expectations.

🐂 Tilray Brands Bull Case

Fair value in this upbeat narrative: US$9.25 per share

Gap to that fair value at the last close of US$7.51: the current price is about 18.8% below this narrative’s fair value estimate

Revenue growth used in this narrative: 2.91% a year

Analysts in this camp are looking for gradual revenue growth with profit margins eventually settling around 20.9%, which supports a higher earnings base over time.

The fair value of US$9.25 reflects assumptions for steadier cash flow visibility, supported by a diversified mix of cannabis, beverage and wellness products across multiple regions.

This view assumes Tilray Brands can sustain its position in key markets while keeping its discount rate at 6.628%, which underpins the present value of those future earnings and cash flows.

🐻 Tilray Brands Bear Case

Fair value in this more cautious narrative: US$1.83 per share

Gap to that fair value at the last close of US$7.51: the current price is about 310.4% above this narrative’s fair value estimate, or a little more than 4x higher

Revenue growth used in this narrative: 5.30% a year

Analysts behind this view are applying a higher 5.30% revenue growth rate but pairing it with concerns about regulation, oversupply, integration and cash flow, which leads to a lower fair value anchor.

The fair value of US$1.83 assumes profit margins move toward about 23.2% and that the shares eventually trade on a P/E of roughly 13.4x, supported by a 6.448% discount rate.

This narrative highlights risks around continued negative free cash flow, potential dilution and execution across both cannabis and beverage assets, which together keep the fair value estimate well below the current share price.

Seeing these side by side can help you decide which assumptions feel more realistic for Tilray Brands, and whether the current US$7.51 share price lines up more with the cautious story or the more optimistic one in your own view.

If you want to read how both cases are built in full and how other investors are thinking about Tilray Brands, Curious how numbers become stories that shape markets? Explore Community Narratives.

Do you think there’s more to the story for Tilray Brands? Head over to our Community to see what others are saying!

NasdaqGS:TLRY 1-Year Stock Price Chart

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include TLRY.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info